Insider Trading & Ownership of Roy D. Baynes

Location: San Diego, CA
Summary: The estimated net worth of Roy D. Baynes is at least $4,926,196 dollars as of 04 Feb 2026. Roy D. Baynes is the Director of Natera, Inc. and owns shares of Natera, Inc. (NTRA) stock worth about $4.22M. Roy D. Baynes is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $687.4K. Roy D. Baynes is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $16.9K.
Signature: /s/ Benjamin Thorner, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Roy D. Baynes files a new Insider Trading report.

Ownership of Roy D. Baynes

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
NTRA	Natera, Inc.	Director	$4,221,899	-$2,809,689	-40%	30 Jan 2026
TVTX	Travere Therapeutics, Inc.	Director	$687,375			15 May 2025
ATRA	Atara Biotherapeutics, Inc.	Director	$16,922			23 Jun 2022
AARD	Aardvark Therapeutics, Inc.	Director				11 Jun 2025
EIKN	Eikon Therapeutics, Inc.	Chief Medical Officer				04 Feb 2026
NRIX	Nurix Therapeutics, Inc.	Director				19 May 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.